HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group (Q44695868)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2004
edit
Language Label Description Also known as
English
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
scientific article published in January 2004

    Statements

    HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group (English)
    S Camilleri-Broët
    A C Hardy-Bessard
    A Le Tourneau
    D Paraiso
    H Orfeuvre
    J Audouin
    E Pujade-Lauraine
    GINECO group
    1 January 2004
    104-112

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit